Clinical Trials Logo

Clinical Trial Summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.


Clinical Trial Description

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to assess, among persons attending a consultation for travel medicine and international vaccines, patients level of knowledge regarding the risk of acquiring MRE, preventive behaviours and the need to inform health professionals that they had recently travelled if the patients require medical care after their return. A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The questionnaire was completed before the planned travel. The travellers answered the questionnaires before seeing the physician. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03339947
Study type Observational
Source CHU de Reims
Contact
Status Completed
Phase N/A
Start date January 1, 2016
Completion date June 1, 2016

See also
  Status Clinical Trial Phase
Completed NCT02625129 - Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic N/A
Completed NCT03306407 - The Effect of Hand Hygiene on Colonization Rates With Multidrug Resistant Enteric Pathogens in Travellers N/A